SEI INVESTMENTS CO - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 204 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$4,557,000
-72.4%
639,100
-7.7%
0.02%
-65.3%
Q4 2019$16,530,000
-8.7%
692,192
+2.5%
0.05%
+6.5%
Q3 2019$18,104,000
+20.7%
675,002
+22.1%
0.05%
-6.1%
Q2 2019$14,994,000
-7.9%
552,657
+17.8%
0.05%
-10.9%
Q1 2019$16,281,000
+263.2%
469,187
+177.8%
0.06%
+243.8%
Q4 2018$4,483,0000.0%168,914
+0.2%
0.02%0.0%
Q3 2018$4,483,000
+5958.1%
168,540
+8451.0%
0.02%
Q2 2018$74,000
-22.1%
1,971
-32.8%
0.00%
Q1 2018$95,000
-65.3%
2,932
-48.0%
0.00%
-100.0%
Q4 2017$274,000
+26.3%
5,635
+40.5%
0.00%0.0%
Q3 2017$217,000
-71.6%
4,010
-73.0%
0.00%
-80.0%
Q4 2015$765,000
-45.1%
14,871
-54.5%
0.01%
-61.5%
Q3 2015$1,393,000
+126.9%
32,671
+142.2%
0.01%
+116.7%
Q2 2015$614,000
+66.4%
13,488
+38.6%
0.01%
+100.0%
Q1 2015$369,0009,7330.00%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,220,672$52,025,0008.00%
Fernwood Investment Management, LLC 190,011$8,098,0007.10%
Cormorant Asset Management, LP 500,000$21,310,0003.40%
HARVEY CAPITAL MANAGEMENT INC 157,930$6,730,0002.69%
Atika Capital Management LLC 128,000$5,456,0002.68%
Redmile Group, LLC 769,641$32,802,0002.48%
Temasek Holdings (Private) Ltd 5,833,568$248,627,0002.36%
SECTORAL ASSET MANAGEMENT INC 1,088,118$46,376,0002.12%
Eventide Asset Management 479,900$20,453,0001.19%
BBT Capital Management, LLC 200,000$8,524,0000.79%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders